11 | Low Float! nothing R3.7 then >10 Total Shares | znewcar1 | 09/30/2024 10:19:21 AM |
10 | $DUO Hod2.2 RL.32 | znewcar1 | 09/30/2024 10:16:37 AM |
9 | $DUO 34% v18,4M c1.01 f56,921M H1.31 ML.6812 | znewcar1 | 06/29/2023 4:40:00 PM |
8 | $DUO 29% v977K c1.62 f6,598M H1.64 | znewcar1 | 03/22/2023 6:39:05 PM |
7 | $DUO 39% v2,5M c1.32 f6,598M H1.375 | znewcar1 | 03/20/2023 6:43:02 PM |
6 | $DUO lod.9 S.8? or less | znewcar1 | 02/13/2023 2:06:02 PM |
5 | $DUO hod1.44 moving on up! a BO3.7 | znewcar1 | 02/03/2023 1:07:12 PM |
4 | $DUO 36% v4,15M c1.94 f5,525M H2.18 ML.6 riding | znewcar1 | 10/28/2022 4:39:41 PM |
3 | LL.18 then pop to 3.85 got S~2 then pushed to | znewcar1 | 10/26/2022 10:16:13 AM |
2 | $DUO HOD1.37 A1.15 a BO1.5 could push 2.7 or | znewcar1 | 10/26/2022 10:14:29 AM |
1 | $DUO 89% v11,2M c1.26 5f,5M H1.52 ML=YL.6 LL.18 | znewcar1 | 10/25/2022 5:17:04 PM |
Recent Articles
- ChangAn's Ambitious Plans for Global Growth by 2030
- Exploring Innovation at the Canton Fair with Jason
- ChangAn's Ambitious 2030 Vision and Global Expansion Plans
- Yutong Bus Revolutionizes Vehicle Service with EnRoute+ Launch
- LONGi's Jiaxing Factory Shines as a Model for Zero-Carbon Innovation
- Bestzyme's Mellia™ Brazzein Gains FDA Approval for Healthier Choices
- Yiwu's Resilient Businesses Thrive Amid Tariff Challenges
- Yutong Bus Introduces Innovative EnRoute+ Service Framework
- Abbott's Volt PFA System: Key Insights on Long-Term Outcomes
- Abbott's Volt PFA System Shows Promising Long-Term Benefits
- Innovative Atrial Fibrillation Solutions by Medtronic
- XploraDEX $XPL Presale Climaxes in Excitement and Urgency
- Legendary Builder Akira Nakai Showcases Talent at Auto Show
- CG Oncology's Cretostimogene Shows Promising Durability in Trials
- Exploring IO Biotech's Impact on Cancer Vaccine Innovation
- Top Muscle Gain Pre-Workouts: Choose the Best for Gains
- Medtronic’s Hugo™ RAS System Achieves Key Clinical Trial Milestone
- Bitcoin Reaches New Heights: Explore Zaminer for Cloud Mining
- Impressive Findings on TAR-200's Efficacy in Bladder Cancer
- TAR-200 Breakthrough: Hope for Bladder Cancer Patients
- Transformative Advancements in Bladder Cancer Treatment by J&J
- Valneva's Chikungunya Vaccine Update: Safety and Recommendations
- XenDex $XDX Presale: 20% Sold in a Day, Analysts Bullish!
- Skyworks Solutions Investors: A Guide to Joining the Class Action
- Baltimore Author Explores Identity in New Space Opera Novel
- Unlocking Innovation: ONO PHARMA's 2025 Golden Ticket Contest
- Chery's HIMLA Series Launch Transforms Pickup Landscape
- Kaldvik AS Achieves Major Milestone with New Share Issuance
- Unlocking Crypto Futures: Explore BexBack's Exciting Offers!
- Understanding China's Economic Direction from Recent Leadership Talks
- Celebrating the Golden Era of Chinese Cinema in 2025
- Yiwugo App Experiences International Success in Sales Growth
- Investors Alert: Join the Geron Corporation Class Action Now
- Exciting Updates on TARA-002's Efficacy Against NMIBC
- ARBOR Technology Highlights Cutting-Edge Automation Innovations
- Class Action Lawsuit Opportunity for Geron Corporation Investors
- Mytheresa and Pucci Unveil Unique Capsule Collection in Style
- Syntech Partners with Meta to Innovate XR Accessory Solutions
- Investors of Ultra Clean Holdings, Inc. Can Join Class Action Now
- Chery Introduces the HIMLA Series, Transforming Pickup Dynamics
- Investors Unite Against Treace Medical Concepts Securities Fraud
- Important Annual Meeting of P/F Atlantic Petroleum Scheduled
- Meizu Impresses with AI Innovations at Global Mobility Expo
- EHR Apps Market Driven by Innovations, Expected to Reach $1.66B
- Exploring Next-Generation Sequencing Data Analysis Growth
- Transforming Retail Financing with LendPro and SPLICE Partnership
- Final Countdown: Join the Exciting $XPL Presale Now!
- Exploring Spark Retainers & BiteSync Class II Corrector Launch
- XenDex Sees Surge in Community Growth and Presale Demand
- Understanding Key Economic Strategies from China's Leadership Meeting